The total cases of novel corona virus (SARS-CoV-2) infections is more than one million and total deaths recorded is more than fifty thousand The research for developing vaccines and drugs against SARS-CoV-2 is going on in different parts of the world Aim of the present study was to identify potential drug candidates against SARS-CoV-2 from existing drugs using in silico molecular modeling and docking The targets for the present study was the spike protein and the main protease of SARS-CoV-2 The study was able to identify some drugs that can either bind to the spike protein receptor binding domain or the main protease of SARS-CoV-2 These include some of the antiviral drugs These drugs might have the potential to inhibit the infection and viral replication
Drug Repurposing to Identify Therapeutics Against COVID 19 with SARS-Cov-2 Spike Glycoprotein and Main Protease as Targets: An in Silico Study